A $24.8 million federal contract will support development a new antiviral drug to treat smallpox. The Biomedical Advanced Research and Development Authority (BARDA), within the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response, will fund the contract with Chimerix, Inc., of Durham, N.C. The contract can be renewed for up to four additional years for a five-year total of up to $81.1 million.
"A critical component of the U.S. strategy for protecting the public against intentional or unintentional release of the smallpox virus is having two smallpox antiviral drugs," says BARDA director Dr. Robin Robinson. "In the event of a smallpox outbreak, a smallpox antiviral could augment our plans to use a vaccine because an antiviral medication can treat people who get the vaccine too late for the vaccine to be effective. An antiviral can save lives."
Routine smallpox vaccination ended in the United States in the early 1970s so people born after routine vaccination ended are not immune to the disease. The World Health Organization declared the disease eradicated worldwide in the 1980s. The variola virus, which causes smallpox, is kept only at the two WHO-approved repositories in the United States and Russia for limited use in research. If the virus were used in a bioterrorism attack, the U.S. government estimates that up to 1.7 million people or more could need treatment before the disease could be controlled through vaccination.
Although the Strategic National Stockpile includes smallpox vaccine, vaccines only protect against disease if a person is vaccinated before or very soon after being exposed to the virus. If further development efforts are successful, CMX-001 could be available to treat people who already have smallpox symptoms. In addition, the medication potentially could be used to treat other virus infections, such as adenovirus, cytomegalovirus, and BK virus, in people with severely weakened immune systems.
The contract uses the federal governments new approach to producing medical countermeasures the medications, vaccines, medical equipment and supplies needed for a health emergency. On Aug. 19, HHS secretary Kathleen Sebelius released an examination of the federal governments system to produce medical countermeasures, along with recommendations for a better approach. The recommendations included developing dual-use drugs drugs that can be used for bioterrorism as well as for other illnesses and to develop more countermeasures that are safe for children, the elderly, and other vulnerable populations such as those with compromised immune systems.
Under the contract, Chimerix will continue developing CMX-001, conduct studies to show that the drug is safe and effective and that the manufacturing process is adequate to ensure the quality of the drug. This work is required for the company to apply for approval of the drug through the U.S. Food and Drug Administration.
BARDA provides a comprehensive integrated portfolio approach to the advanced research and development, stockpile acquisition, innovation, and manufacturing infrastructure building of the necessary vaccines, drugs, therapeutics, diagnostic tools, and non-pharmaceutical products such as ventilators for public health medical emergencies including chemical, biological, radiological, and nuclear threats, pandemic influenza, and other emerging infectious diseases.
For more information about BARDA and ASPR preparedness efforts for public health and medical emergencies, including the medical countermeasure review, visit www.phe.gov.
The Strategic National Stockpile (SNS), operated by the Centers for Disease Control and Prevention, has large quantities of medicine and medical supplies to protect the American public if there is a public health emergency, such as a terrorist attack or flu outbreak, severe enough to cause local supplies to run out. Once federal and local authorities agreed that the SNS supplies were needed medicines could be delivered to any state in the United States within 12 hours. Each state has plans to receive and distribute SNS medicine and medical supplies to local communities as quickly as possible. To learn more, visit http://emergency.cdc.gov/stockpile/
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.
CenTrak Unveils Revolutionary BLE Multi-Mode Platform for Health Care RTLS Solutions
March 22nd 2024CenTrak, the industry leader in real-time location technology, introduces the groundbreaking BLE Multi-Mode Platform, setting a new standard for Real-Time Location Systems (RTLS) in health care. Discover how this innovative solution enhances location data precision and streamlines operations for health care organizations.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.
CenTrak Unveils Revolutionary BLE Multi-Mode Platform for Health Care RTLS Solutions
March 22nd 2024CenTrak, the industry leader in real-time location technology, introduces the groundbreaking BLE Multi-Mode Platform, setting a new standard for Real-Time Location Systems (RTLS) in health care. Discover how this innovative solution enhances location data precision and streamlines operations for health care organizations.
2 Commerce Drive
Cranbury, NJ 08512